Clinical-Stage Pharma

12 articles in this category

Stock Weather AIBiotechnologyClinical-Stage Pharma

Arcus Biosciences – 2026-01-15 - Increase Confidence 7/10

Negative free cash flow contrasts with analyst optimism and undervaluation thesis, driven by upcoming clinical trial catalysts suggesting near-term upside.

Jan 15, 2026RCUS

Stock Weather AIBiotechnologyClinical-Stage Pharma

Crinetics Pharmaceuticals – 2026-01-07 - Increase Confidence 7/10

Negative free cash flow and high debt are offset by imminent clinical data readouts and bullish analyst targets, creating near-term catalyst-driven upside potential.

Jan 7, 2026CRNX

Stock Weather AIBiotechnologyClinical-Stage Pharma

Revolution Medicines – 2026-01-07 - increase Confidence 8/10

Strong cash runway and positive trial data for RMC-6236 in pancreatic cancer signal near-term upside despite negative free cash flow.

Jan 7, 2026RVMD

Stock Weather AIBiotechnologyClinical-Stage Pharma

ABIVAX – 2025-12-22 - Increase Confidence 6/10

Strong Buy consensus and late-stage clinical catalysts outweigh negative cash flow, with near-term upside likely on ulcerative colitis Phase 3 readout anticipation.

Dec 22, 2025ABVX

Stock Weather AIBiotechnologyClinical-Stage Pharma

Disc Medicine, Inc. – 2025-12-19 - increase Confidence 6/10

Negative free cash flow and high leverage offset by strong analyst consensus and upcoming catalysts in hematologic drug development; stock likely to rise near-term on biotech sector momentum.

Dec 19, 2025IRON

Stock Weather AIBiotechnologyClinical-Stage Pharma

Olema Pharmaceuticals – 2025-12-19 - Increase Confidence 8/10

Negative free cash flow offset by strong analyst momentum and recent trial validation, signaling near-term upside for OLMA.

Dec 19, 2025OLMA

Stock Weather AIBiotechnologyClinical-Stage Pharma

Olema Pharmaceuticals – 2025-12-15 - Increase Confidence 7/10

Strong analyst consensus and robust cash reserves support upside, with palazestrant Phase 3 momentum acting as a near-term catalyst for OLMA.

Dec 15, 2025OLMA

Stock Weather AIBiotechnologyClinical-Stage Pharma

Centessa Pharmaceuticals – 2025-12-11 - Increase Confidence 7/10

Negative free cash flow offset by strong analyst backing and upcoming pipeline catalysts suggest near-term upside for CNTA.

Dec 11, 2025CNTA

Stock Weather AIBiotechnologyClinical-Stage Pharma

Kymera Therapeutics – 2025-12-08 - Increase Confidence 8/10

Negative free cash flow offset by strong cash runway and recent pipeline catalysts; first patient dosed in Phase 2b trial drives near-term upside.

Dec 8, 2025KYMR

Stock Weather AIBiotechnologyClinical-Stage Pharma

Wave Life Sciences – 2025-12-08 - Increase Confidence 7/10

Positive pipeline data and strong analyst sentiment outweigh near-term dilution risk from $250M share offering, signaling short-term upside.

Dec 8, 2025WVE

Stock Weather AIBiotechClinical-Stage Pharma

Terns Pharmaceuticals – 2025-11-18 - Increase Confidence 7/10

Negative free cash flow offset by strong cash runway and imminent TERN-701 data catalyst in December → near-term upside likely.

Nov 18, 2025TERN

Stock Weather AIBiotechnologyClinical-Stage Pharma

Terns Pharmaceuticals – 2025-11-17 - Increase Confidence 8/10

Strong cash runway and rising R&D spend align with upcoming TERN-701 data catalyst, driving near-term upside potential.

Nov 17, 2025TERN